Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Histological Analysis of Term Placentas from Hyperimmune Globulin-Treated and Untreated Mothers with Primary Cytomegalovirus Infection.

Gabrielli L, Bonasoni MP, Foschini MP, Silini EM, Spinillo A, Revello MG, Chiereghin A, Piccirilli G, Petrisli E, Turello G, Simonazzi G, Gibertoni D, Lazzarotto T.

Fetal Diagn Ther. 2019;45(2):111-117. doi: 10.1159/000487302. Epub 2018 Apr 23.

PMID:
29684915
2.

The pentameric complex of human Cytomegalovirus: cell tropism, virus dissemination, immune response and vaccine development.

Gerna G, Revello MG, Baldanti F, Percivalle E, Lilleri D.

J Gen Virol. 2017 Sep;98(9):2215-2234. doi: 10.1099/jgv.0.000882. Epub 2017 Aug 15. Review.

PMID:
28809151
3.

Assessing Immunity to Rubella Virus: a Plea for Standardization of IgG (Immuno)assays.

Bouthry E, Furione M, Huzly D, Ogee-Nwankwo A, Hao L, Adebayo A, Icenogle J, Sarasini A, Revello MG, Grangeot-Keros L, Vauloup-Fellous C.

J Clin Microbiol. 2016 Jul;54(7):1720-1725. doi: 10.1128/JCM.00383-16. Epub 2016 May 4.

4.

Prevention of Primary Cytomegalovirus Infection in Pregnancy.

Revello MG, Tibaldi C, Masuelli G, Frisina V, Sacchi A, Furione M, Arossa A, Spinillo A, Klersy C, Ceccarelli M, Gerna G, Todros T; CCPE Study Group.

EBioMedicine. 2015 Aug 6;2(9):1205-10. doi: 10.1016/j.ebiom.2015.08.003. eCollection 2015 Sep.

5.

Primary human cytomegalovirus infections: kinetics of ELISA-IgG and neutralizing antibody in pauci/asymptomatic pregnant women vs symptomatic non-pregnant subjects.

Fornara C, Furione M, Lilleri D, Cane I, Revello MG, Zavattoni M, Gerna G.

J Clin Virol. 2015 Mar;64:45-51. doi: 10.1016/j.jcv.2015.01.004. Epub 2015 Jan 6.

PMID:
25728078
6.

Cytomegalovirus DNAemia in pregnant women.

Revello MG, Furione M, Rognoni V, Arossa A, Gerna G.

J Clin Virol. 2014 Dec;61(4):590-2. doi: 10.1016/j.jcv.2014.10.002. Epub 2014 Oct 18.

PMID:
25457128
7.

Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host.

Gerna G, Lilleri D, Fornara C, Bruno F, Gabanti E, Cane I, Furione M, Revello MG.

J Gen Virol. 2015 Feb;96(Pt 2):360-9. doi: 10.1099/vir.0.070441-0. Epub 2014 Oct 14.

PMID:
25316796
8.

Role of human cytomegalovirus (HCMV)-specific antibody in HCMV-infected pregnant women.

Revello MG, Fornara C, Arossa A, Zelini P, Lilleri D.

Early Hum Dev. 2014 Mar;90 Suppl 1:S32-4. doi: 10.1016/S0378-3782(14)70011-8. Review.

PMID:
24709453
9.

A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus.

Revello MG, Lazzarotto T, Guerra B, Spinillo A, Ferrazzi E, Kustermann A, Guaschino S, Vergani P, Todros T, Frusca T, Arossa A, Furione M, Rognoni V, Rizzo N, Gabrielli L, Klersy C, Gerna G; CHIP Study Group.

N Engl J Med. 2014 Apr 3;370(14):1316-26. doi: 10.1056/NEJMoa1310214.

10.

Clinical evaluation of the Roche Elecsys CMV IgG Avidity assay.

Vauloup-Fellous C, Lazzarotto T, Revello MG, Grangeot-Keros L.

Eur J Clin Microbiol Infect Dis. 2014 Aug;33(8):1365-9. doi: 10.1007/s10096-014-2080-4. Epub 2014 Mar 2.

11.

Evaluation of fully automated assays for the detection of Rubella IgM and IgG antibodies by the Elecsys(®) immunoassay system.

van Helden J, Grangeot-Keros L, Vauloup-Fellous C, Vleminckx R, Masset F, Revello MG.

J Virol Methods. 2014 Apr;199:108-15. doi: 10.1016/j.jviromet.2014.01.009. Epub 2014 Jan 30.

PMID:
24487099
12.

Slow increase in IgG avidity correlates with prevention of human cytomegalovirus transmission to the fetus.

Furione M, Rognoni V, Sarasini A, Zavattoni M, Lilleri D, Gerna G, Revello MG.

J Med Virol. 2013 Nov;85(11):1960-7. doi: 10.1002/jmv.23691. Epub 2013 Jul 25.

PMID:
23893782
13.

Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH/gL/pUL128-130-131 complex during primary infection.

Lilleri D, Kabanova A, Revello MG, Percivalle E, Sarasini A, Genini E, Sallusto F, Lanzavecchia A, Corti D, Gerna G.

PLoS One. 2013;8(3):e59863. doi: 10.1371/journal.pone.0059863. Epub 2013 Mar 29.

14.

Clinical evaluation of new automated cytomegalovirus IgM and IgG assays for the Elecsys(®) analyser platform.

Revello MG, Vauloup-Fellous C, Grangeot-Keros L, van Helden J, Dickstein Y, Lipkin I, Mühlbacher A, Lazzarotto T.

Eur J Clin Microbiol Infect Dis. 2012 Dec;31(12):3331-9. doi: 10.1007/s10096-012-1700-0. Epub 2012 Aug 1.

PMID:
22850741
15.

Lack of seasonality of primary human cytomegalovirus infection in pregnancy.

Formica M, Furione M, Zavattoni M, Rognoni V, Arossa A, Nazifi M, Revello MG.

J Clin Virol. 2012 Apr;53(4):370-1. doi: 10.1016/j.jcv.2011.12.032. Epub 2012 Jan 23. No abstract available.

PMID:
22277725
16.

Kinetics of effector functions and phenotype of virus-specific and γδ T lymphocytes in primary human cytomegalovirus infection during pregnancy.

Fornara C, Lilleri D, Revello MG, Furione M, Zavattoni M, Lenta E, Gerna G.

J Clin Immunol. 2011 Dec;31(6):1054-64. doi: 10.1007/s10875-011-9577-8. Epub 2011 Aug 17.

PMID:
21847524
17.

Serum antibody response to the gH/gL/pUL128-131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections.

Genini E, Percivalle E, Sarasini A, Revello MG, Baldanti F, Gerna G.

J Clin Virol. 2011 Oct;52(2):113-8. doi: 10.1016/j.jcv.2011.06.018. Epub 2011 Aug 4.

PMID:
21820353
18.

Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: a 20-year experience.

Revello MG, Fabbri E, Furione M, Zavattoni M, Lilleri D, Tassis B, Quarenghi A, Cena C, Arossa A, Montanari L, Rognoni V, Spinillo A, Gerna G.

J Clin Virol. 2011 Apr;50(4):303-7. doi: 10.1016/j.jcv.2010.12.012. Epub 2011 Feb 1.

PMID:
21277825
19.

Prognostic markers of symptomatic congenital human cytomegalovirus infection in fetal blood.

Fabbri E, Revello MG, Furione M, Zavattoni M, Lilleri D, Tassis B, Quarenghi A, Rustico M, Nicolini U, Ferrazzi E, Gerna G.

BJOG. 2011 Mar;118(4):448-56. doi: 10.1111/j.1471-0528.2010.02822.x. Epub 2010 Dec 24.

20.

Comparative evaluation of eight commercial human cytomegalovirus IgG avidity assays.

Revello MG, Genini E, Gorini G, Klersy C, Piralla A, Gerna G.

J Clin Virol. 2010 Aug;48(4):255-9. doi: 10.1016/j.jcv.2010.05.004. Epub 2010 Jun 18.

PMID:
20561816
21.

Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications.

Revello MG, Gerna G.

Rev Med Virol. 2010 May;20(3):136-55. doi: 10.1002/rmv.645. Review.

PMID:
20084641
22.

Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex.

Macagno A, Bernasconi NL, Vanzetta F, Dander E, Sarasini A, Revello MG, Gerna G, Sallusto F, Lanzavecchia A.

J Virol. 2010 Jan;84(2):1005-13. doi: 10.1128/JVI.01809-09. Epub 2009 Nov 4.

23.

Case 4-2009: a pregnant woman with fever after a trip to Africa.

Revello MG.

N Engl J Med. 2009 Jun 4;360(23):2482; author reply 2482. No abstract available.

PMID:
19504768
24.

Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host.

Lilleri D, Zelini P, Fornara C, Comolli G, Revello MG, Gerna G.

Clin Immunol. 2009 Jun;131(3):395-403. doi: 10.1016/j.clim.2009.02.002. Epub 2009 Mar 5.

PMID:
19268633
25.

Human cytomegalovirus-specific memory CD8+ and CD4+ T cell differentiation after primary infection.

Lilleri D, Fornara C, Revello MG, Gerna G.

J Infect Dis. 2008 Aug 15;198(4):536-43. doi: 10.1086/590118.

PMID:
18590456
26.

Molecular epidemiology of primary human cytomegalovirus infection in pregnant women and their families.

Revello MG, Campanini G, Piralla A, Furione M, Percivalle E, Zavattoni M, Gerna G.

J Med Virol. 2008 Aug;80(8):1415-25. doi: 10.1002/jmv.21243.

PMID:
18551604
27.

Maternal, fetal and neonatal diagnosis of congenital human cytomegalovirus infection.

Revello MG, Gerna G.

Expert Opin Med Diagn. 2008 May;2(5):547-63. doi: 10.1517/17530059.2.5.547.

PMID:
23495743
28.

Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection.

Gerna G, Sarasini A, Patrone M, Percivalle E, Fiorina L, Campanini G, Gallina A, Baldanti F, Revello MG.

J Gen Virol. 2008 Apr;89(Pt 4):853-65. doi: 10.1099/vir.0.83523-0.

PMID:
18343825
29.

Human cytomegalovirus (HCMV) DNAemia in the mother at amniocentesis as a risk factor for iatrogenic HCMV infection of the fetus.

Revello MG, Furione M, Zavattoni M, Tassis B, Nicolini U, Fabbri E, Gerna G.

J Infect Dis. 2008 Feb 15;197(4):593-6. doi: 10.1086/526499.

PMID:
18275277
30.

Cytomegalovirus (CMV) IE1- and pp65-specific CD8+ T cell responses broaden over time after primary CMV infection in infants.

Gibson L, Dooley S, Trzmielina S, Somasundaran M, Fisher D, Revello MG, Luzuriaga K.

J Infect Dis. 2007 Jun 15;195(12):1789-98. Epub 2007 May 8.

PMID:
17492595
31.

Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus.

Lilleri D, Fornara C, Furione M, Zavattoni M, Revello MG, Gerna G.

J Infect Dis. 2007 Apr 1;195(7):1062-70. Epub 2007 Feb 20.

PMID:
17330798
32.

Preconceptional primary human cytomegalovirus infection and risk of congenital infection.

Revello MG, Zavattoni M, Furione M, Fabbri E, Gerna G.

J Infect Dis. 2006 Mar 15;193(6):783-7. Epub 2006 Feb 9.

PMID:
16479511
33.

Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients.

Gerna G, Vitulo P, Rovida F, Lilleri D, Pellegrini C, Oggionni T, Campanini G, Baldanti F, Revello MG.

J Med Virol. 2006 Mar;78(3):408-16. Erratum in: J Med Virol. 2008 Oct;80(10):1869.

PMID:
16419110
34.

Prediction of endothelial cell tropism of human cytomegalovirus strains.

Gerna G, Sarasini A, Genini E, Percivalle E, Revello MG.

J Clin Virol. 2006 Apr;35(4):470-3. Epub 2006 Jan 18. No abstract available.

PMID:
16413824
35.

Passive immunization against cytomegalovirus during pregnancy.

Revello MG.

N Engl J Med. 2005 Dec 29;353(26):2818-20; author reply 2818-20. No abstract available.

PMID:
16382550
36.

Human cytomegalovirus UL131A, UL130 and UL128 genes are highly conserved among field isolates.

Baldanti F, Paolucci S, Campanini G, Sarasini A, Percivalle E, Revello MG, Gerna G.

Arch Virol. 2006 Jun;151(6):1225-33. Epub 2005 Dec 29.

PMID:
16380811
37.

Lymphoproliferative response in primary human cytomegalovirus (HCMV) infection is delayed in HCMV transmitter mothers.

Revello MG, Lilleri D, Zavattoni M, Furione M, Genini E, Comolli G, Gerna G.

J Infect Dis. 2006 Jan 15;193(2):269-76. Epub 2005 Dec 9.

PMID:
16362891
38.

Rapid detection of human metapneumovirus strains in nasopharyngeal aspirates and shell vial cultures by monoclonal antibodies.

Percivalle E, Sarasini A, Visai L, Revello MG, Gerna G.

J Clin Microbiol. 2005 Jul;43(7):3443-6.

39.

Changing circulation rate of human metapneumovirus strains and types among hospitalized pediatric patients during three consecutive winter-spring seasons. Brief report.

Gerna G, Campanini G, Rovida F, Sarasini A, Lilleri D, Paolucci S, Marchi A, Baldanti F, Revello MG.

Arch Virol. 2005 Nov;150(11):2365-75. Epub 2005 Jun 28.

PMID:
15986171
40.
41.

Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients.

Gerna G, Lilleri D, Zecca M, Alessandrino EP, Baldanti F, Revello MG, Locatelli F.

Haematologica. 2005 Apr;90(4):526-33.

42.

Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells.

Gerna G, Percivalle E, Lilleri D, Lozza L, Fornara C, Hahn G, Baldanti F, Revello MG.

J Gen Virol. 2005 Feb;86(Pt 2):275-84.

PMID:
15659746
43.

Monoclonal antibodies versus reverse transcription-PCR for detection of respiratory viruses in a patient population with respiratory tract infections admitted to hospital.

Rovida F, Percivalle E, Zavattoni M, Torsellini M, Sarasini A, Campanini G, Paolucci S, Baldanti F, Revello MG, Gerna G.

J Med Virol. 2005 Feb;75(2):336-47.

PMID:
15602736
44.

Congenital rubella infection following rubella outbreak in northern Italy, 2002: need for an effective vaccination programme.

Revello MG, Gorini G, Zavattoni M, Furione M, Gerna G.

Eur J Clin Microbiol Infect Dis. 2004 Oct;23(10):780-3.

PMID:
15368099
45.

Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes.

Hahn G, Revello MG, Patrone M, Percivalle E, Campanini G, Sarasini A, Wagner M, Gallina A, Milanesi G, Koszinowski U, Baldanti F, Gerna G.

J Virol. 2004 Sep;78(18):10023-33. Erratum in: J Virol. 2009 Jun;83(12):6323.

46.
47.

Rubella control in Italy.

Ciofi degli Atti M, Filia A, Revello MG, Buffolano W, Salmaso S.

Euro Surveill. 2004 Apr;9(4):19-21.

PMID:
15192262
48.

Pathogenesis of human cytomegalovirus infection and cellular targets.

Gerna G, Baldanti F, Revello MG.

Hum Immunol. 2004 May;65(5):381-6. Review.

PMID:
15172435
49.

Rubella control in Italy.

Ciofi Degli Atti ML, Filia A, Revello MG, Buffolano W, Salmaso S.

Euro Surveill. 2004 Apr;9(4):17-18. doi: 10.2807/esm.09.04.00462-en.

PMID:
29183465
50.

Monitoring of human cytomegalovirus (HCMV)-specific CD4+ T cell frequency by cytokine flow cytometry as a possible indicator for discontinuation of HCMV secondary prophylaxis in HAART-treated AIDS patients.

Lilleri D, Piccinini G, Genini E, Comolli G, Chiesa A, Tordato F, Sotgiu G, Parisi A, Baldanti F, Revello MG, Gerna G.

J Clin Virol. 2004 Apr;29(4):297-307.

PMID:
15018859

Supplemental Content

Loading ...
Support Center